Drugs / Novolin®
last change Apr 2013 re-read 3 minutes ago

Novolin®

Developed for
type 1 diabetes mellitus

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 3 NCT01308437 Comparator Mar 2011 → Apr 2013 type 1 diabetes mellitus Wockhardt Terminated No outcome recorded Stop: Business

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Novolin ClinicalTrials.gov intervention name — accepted as the source's own label NCT01308437 ↗